<?xml version="1.0" encoding="utf8"?>
 <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd"> <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Short Communication" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JRNM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Radiation and Nuclear Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2766-8630</issn>
      <publisher>
        <publisher-name>Open Access Pub</publisher-name>
        <publisher-loc>United States</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.14302/issn.2766-8630.jrnm-22-4093</article-id>
      <article-id pub-id-type="publisher-id">JRNM-22-4093</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dual Energy Computed Tomography and Effect on the Management of Uric Acid Renal Calculi</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jahangiri</surname>
            <given-names>AJ</given-names>
          </name>
          <xref ref-type="aff" rid="idm1839857316">1</xref>
          <xref ref-type="aff" rid="idm1839855516">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moghaddam</surname>
            <given-names>AM</given-names>
          </name>
          <xref ref-type="aff" rid="idm1839857316">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1839857316">
        <label>1</label>
        <addr-line>Department of radiology, Liverpool Hospital, Elizabeth street, Liverpool, NSW, 2170</addr-line>
      </aff>
      <aff id="idm1839855516">
        <label>*</label>
        <addr-line>corresponding Author </addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Anubha</surname>
            <given-names>Bajaj</given-names>
          </name>
          <xref ref-type="aff" rid="idm1839979860">1</xref>
        </contrib>
      </contrib-group>
      <aff id="idm1839979860">
        <label>1</label>
        <addr-line>India</addr-line>
      </aff>
      <author-notes>
        <corresp>Jahangiri AJ, Department of radiology, Liverpool Hospital, Elizabeth street, Liverpool, NSW, 2170.<email>alborz_jahangiri@yahoo.com</email></corresp>
        <fn fn-type="conflict" id="idm1841215444">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub" iso-8601-date="2023-03-27">
        <day>27</day>
        <month>03</month>
        <year>2023</year>
      </pub-date>
      <volume>1</volume>
      <issue>2</issue>
      <fpage>13</fpage>
      <lpage>18</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>02</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>02</month>
          <year>2022</year>
        </date>
        <date date-type="online">
          <day>27</day>
          <month>03</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>Jahangiri AJ, et al.</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://openaccesspub.org/jrnm/article/1926">This article is available from http://openaccesspub.org/jrnm/article/1926</self-uri>
      <abstract>
        <p>Attenuation differences from 2 x-ray sources allow differentiation and characterization of stone types with similar radiation dose                 compared to single-energy CT scan. The difference is shown in colours, allowing preoperative              prediction and management of stones. </p>
        <p>We determined the effect of DECT-KUB on urological management of patients with uric acid stones since it was first introduced in our centre.</p>
        <p>50 patients with uric acid stones were             selected from 2 year groups, each with 25 patients and their urological managements were reviewed retrospectively. </p>
        <p>We concluded that DECT-KUB is an accurate way of determining the chemical characteristics of renal calculi and can alter patients’ management. It has gained wide acceptance among clinicians in our centre and is now widely used to plan urological management of patients with renal calculi. Based on urological management comparison of patients who presented in the year 2011 with uric acid stones and patients in the year 2020, we concluded that patients with uric acid stones based on DECT-KUB findings can start dissolution therapy instead of surgical            extraction or lithotripsy prior to biochemical analysis results become available. Although utility of                 DECT-KUB is widely accepted among clinicians in our centre it may not be available worldwide and this is the limiting factor in its universal use.</p>
      </abstract>
      <kwd-group>
        <kwd>OHIP-14</kwd>
        <kwd>oral health</kwd>
        <kwd>oral health status indicators</kwd>
        <kwd>perceived health</kwd>
        <kwd>quality of life</kwd>
        <kwd>senior citizens</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="2"/>
        <page-count count="6"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="idm1839707364" sec-type="intro">
      <title>Introduction</title>
      <p>In Dual energy CT scanning, Attenuation               differences from two x-ray sources allow differentiation and characterization of stone types <xref ref-type="bibr" rid="ridm1841593220">1</xref>.</p>
      <p>The attenuation difference is shown in                 colors. In <xref ref-type="fig" rid="idm1840523612">graph 1</xref>, the 1.15 ratio represents threshold between uric acid and other stones.  If a data point corresponding to a stone with unknown composition falls below this line, the algorithm will characterize such stone as a UA stone and will assign it a predefined red color. And if it falls above the line it will be identified as a non-UA stone and will be shown blue <xref ref-type="bibr" rid="ridm1841659252">2</xref>.</p>
      <fig id="idm1840523612">
        <label>Graph 1.</label>
        <caption>
          <title/>
        </caption>
        <graphic xlink:href="images/image1.jpg" mime-subtype="jpg"/>
      </fig>
      <p>It has been reported in the previous studies that, although two x-ray sources are used, the radiation dose is not doubled. In fact with the new low dose techniques the dose is similar to those of single energy CT scanning. It is a useful tool to predict the stone type preoperatively and it can aid in choosing the appropriate therapy <xref ref-type="bibr" rid="ridm1841593220">1</xref><xref ref-type="bibr" rid="ridm1841659252">2</xref>.</p>
      <p>The lifetime risk of developing kidney stones is about 1 in 10 for Australian men and 1 in 35 for women. Renal stones account for about 1 in every 100 hospital admissions.</p>
      <p>10% of all first time stone formers will get           another episode within 1 year. According to the type, size and location of the stone the management changes              significantly. For stones less than 2 cm in the kidney ESWL is usually used with X-ray or USS guidance in theatre.</p>
      <p>Stones in the ureters with no chance of                    spontaneous passage (that being often larger than 5mm) are treated with Ureteroscopy and basket extraction of the stones with or without laser lithotripsy.  PCNL is an               invasive of all, which is reserved for stones bigger than             2 cm.</p>
      <p>Medical dissolution therapy is a useful                non-invasive method of treating uric acid stone  Sodium bicarbonate is used to keep the urine PH above 7 to               dissolve the uric acid stones in a less acidic urine and             Allopurinol is used to decrease the Urate level. And of course hydration and diet play important role <xref ref-type="bibr" rid="ridm1841666524">3</xref><xref ref-type="bibr" rid="ridm1841453908">4</xref>. </p>
      <p>Sometimes Ureteroscopy and laser lithotripsy is used for fragmentation of the stones to increase the         surface area of the stone prior to dissolution therapy (specially for stones&gt; 2cm) <xref ref-type="bibr" rid="ridm1841447932">5</xref><xref ref-type="bibr" rid="ridm1841439964">6</xref>.</p>
      <p>Stone analysis, together with serum and 24-hour urine metabolic evaluation, can identify the etiology in more than 95% of patients <xref ref-type="bibr" rid="ridm1841593220">1</xref>. Preoperative prediction of stone type (<xref ref-type="fig" rid="idm1840521380">figure 1</xref> and <xref ref-type="fig" rid="idm1840527860">figure 2</xref>) is crucial for therapeutic                  decision making and follow-up <xref ref-type="bibr" rid="ridm1841659252">2</xref><xref ref-type="bibr" rid="ridm1841666524">3</xref><xref ref-type="bibr" rid="ridm1841453908">4</xref><xref ref-type="bibr" rid="ridm1841447932">5</xref><xref ref-type="bibr" rid="ridm1841439964">6</xref>. Some studies have reported predictive role of dual energy CT scan for                 determination of stone type <xref ref-type="bibr" rid="ridm1841437876">7</xref><xref ref-type="bibr" rid="ridm1841424724">8</xref><xref ref-type="bibr" rid="ridm1841422780">9</xref>.</p>
      <p>In this study we determined the effect of                   DECT-KUB on urological management of patients with uric acid stones since DECT-KUB was first introduced in our center in 2011.</p>
      <fig id="idm1840521380">
        <label>Figure 1.</label>
        <caption>
          <title/>
        </caption>
        <graphic xlink:href="images/image2.jpg" mime-subtype="jpg"/>
      </fig>
      <fig id="idm1840527860">
        <label>Figure 2.</label>
        <caption>
          <title/>
        </caption>
        <graphic xlink:href="images/image3.jpg" mime-subtype="jpg"/>
      </fig>
    </sec>
    <sec id="idm1839703332" sec-type="materials">
      <title>Materials and Methods</title>
      <p>Our center has been using DECT-KUB for                   diagnosis of renal stones since January 2011. </p>
      <p>All CTKUB studies performed at the Princess           Alexandra Hospital since January 2011 were identified                                 retrospectively from Agfa PACS database. Scans were               performed using standard DECT CTKUB protocol on                Siemens Definition Flash CT and reconstructed with               Siemens Renal Calculus analysis software.</p>
      <p>271 patients who underwent DECT-KUB in the year 2011 for suspected or known urinary stone and 256 patients from the year 2020 were reviewed irrespective of their age and gender and stone size and location.50                 patients who were diagnosed with uric acid renal calculus based on DE software results were selected from the 2 groups.</p>
      <p>Medical charts were reviewed retrospectively, irrespective of the patients’ age, gender and location of the stones.</p>
      <p>Patients with uric acid stones who passed the stones spontaneously without any interventions were    excluded from this study. All 50 selected patients also had biochemical analysis confirming the diagnosis after either straining urine by the patients and collecting the stones or surgical extraction of the stones for analysis. They were assigned to two groups and each group with 25 patients. Group one were the patients from when the DECT first started its application for renal calculus diagnosis in our center from January 2011 till January 2012 and the second group was from January 2020 till January 2021, after 10 years of diagnosing renal stones and their types in our center with DECT.</p>
      <p>The number of patients in each group who                    underwent dissolution therapy straight after the diagnosis with DECT and the ones who underwent invasive surgical extraction or lithotripsy was compared in two groups. </p>
    </sec>
    <sec id="idm1839693484" sec-type="results">
      <title>Results and Discussion</title>
      <p>From group one, 15 patients (60%) with uric acid stones underwent dissolution therapy after diagnosis with DECT-KUB, 10 patients (40%) underwent invasive                surgical procedures after stent insertion and only started on dissolution therapy after the biochemical analysis            results confirmed the diagnosis of uric acid stone.</p>
      <p>In the second group, 23 patients (92%) started on dissolution therapy straight after the diagnosis with DECT-KUB, 2 patients (8%) stented secondary to obstructive vesico-ureteric stones. Findings were statistically                       significant (P-value &lt;0.01, Z-value 5.3) when compared in the two groups. <xref ref-type="table" rid="idm1840508660">Table 1</xref>, <xref ref-type="table" rid="idm1840475380">Table 2</xref></p>
      <table-wrap id="idm1840508660">
        <label>Table 1.</label>
        <caption>
          <title> Patients who passed the stone without any intervention and stones &gt;2cm were excluded.</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td>Group A(Jan2011-Jan2012)</td>
              <td>Group B(Jan2020-Jan2021)</td>
              <td>Overall</td>
            </tr>
            <tr>
              <td>271</td>
              <td>264</td>
              <td>535</td>
            </tr>
            <tr>
              <td>27 uric acid stones</td>
              <td>26 uric acid stones</td>
              <td>53(10%)</td>
            </tr>
            <tr>
              <td>2 patients excluded</td>
              <td>1 patient excluded</td>
              <td>3</td>
            </tr>
            <tr>
              <td>25 included in the study</td>
              <td>25 included in the study</td>
              <td>50</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="idm1840475380">
        <label>Table 2.</label>
        <caption>
          <title> findings were statistically significant when compared in 2 groups. P-value 0.01</title>
        </caption>
        <table rules="all" frame="box">
          <tbody>
            <tr>
              <td> </td>
              <td>Dissolution therapy</td>
              <td>Surgical intervention</td>
              <td>Total</td>
            </tr>
            <tr>
              <td>Group A</td>
              <td>15(60%)</td>
              <td>10(40%)</td>
              <td>25</td>
            </tr>
            <tr>
              <td>Group B</td>
              <td>23(92%)</td>
              <td>2(8%)</td>
              <td>25</td>
            </tr>
            <tr>
              <td>Total</td>
              <td>38(76%)</td>
              <td>12(24%)</td>
              <td>50</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p> </p>
    </sec>
    <sec id="idm1839682076" sec-type="conclusions">
      <title>Conclusion</title>
      <p>DECT-KUB stone characterization is an accurate method for the chemical characterization of urinary stones, and can alter patient management <xref ref-type="bibr" rid="ridm1841593220">1</xref><xref ref-type="bibr" rid="ridm1841659252">2</xref><xref ref-type="bibr" rid="ridm1841666524">3</xref><xref ref-type="bibr" rid="ridm1841453908">4</xref><xref ref-type="bibr" rid="ridm1841447932">5</xref>. Studies of 40 human renal stones of known composition from 2-7 mm, showed that DECT is 100% accurate and 100% sensitive for patients with normal weight <xref ref-type="bibr" rid="ridm1841437876">7</xref>. Other in vivo studies had the sensitivity and accuracy of 74-100% and 89-100% respectively <xref ref-type="bibr" rid="ridm1841403876">11</xref><xref ref-type="bibr" rid="ridm1841401788">12</xref>. </p>
      <p>Radiation dose in DECT is not doubled. In fact, the images are acquired with lower radiation dose when                compared to the early scanners and yet the quality and resolution of the images produced with low dose DECT techniques are high (2).</p>
      <p>Since the introduction of DECT-KUB in our center in January 2011, it gained wide acceptance among                  clinicians and management plans were formed based on DECT-KUB findings. Our data confirms that DECT is an accurate and reliable method for chemical                                  characterization of urinary stones, being 100% specific for UA stones and can alter patient management. It was              89-100% accurate and 74-100% sensitive for chemical characterization in previous studies <xref ref-type="bibr" rid="ridm1841437876">7</xref><xref ref-type="bibr" rid="ridm1841424724">8</xref><xref ref-type="bibr" rid="ridm1841422780">9</xref><xref ref-type="bibr" rid="ridm1841426164">10</xref>.</p>
      <p>92% of our patients in the second group with uric acid stones started on dissolution therapy before the              biochemical analysis became available and this was              compared to 60% in the first group when DECT was first introduced in our system for diagnosis and investigation of stone types. Our study showed that DECT-KUB in the period of 10 years helped managing the patients with uric acid stones with dissolution therapy instead of surgical extraction or lithotripsy reducing the number of invasive procedures by 32 % on urate stones in this study, before even the biochemical analysis became available.</p>
      <p>One drawback is that it does the chemical analysis based on the material on the surface of the stones. Which may not always be what the stone is fully made of in case of mixed stones <xref ref-type="bibr" rid="ridm1841395596">13</xref>. Other limiting factor in using DECT is the availability of CT scanners with dual energy                scanning capabilities. Which can limit the universal use of DECT for diagnosis of renal stones <xref ref-type="bibr" rid="ridm1841393364">14</xref>.</p>
      <sec id="idm1839656716">
        <title>Abbreviations</title>
        <p>DECT-KUB) dual energy computed tomography-kidney ureter bladder</p>
        <p>(ESWL) endoscopic shock wave lithotripsy</p>
        <p>(PCNL) percutanoues nephrolithotomy.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ridm1841593220">
        <label>1.</label>
        <mixed-citation xlink:type="simple" publication-type="book"><date><year>2011</year></date><chapter-title>Dual energy CT in Clinical Practice’</chapter-title>
Kidney Stones ’(chapter) in T.R.C. Johnson (eds.)
<publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin, Heidelberg</publisher-loc></mixed-citation>
      </ref>
      <ref id="ridm1841659252">
        <label>2.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <article-title>Dual source computed tomography: a novel technique to determine stone composition”</article-title>
          <date>
            <year>2008</year>
          </date>
          <source>Nov [Journal Article]</source>
          <volume>72</volume>
          <issue>5</issue>
          <fpage>1164</fpage>
          <lpage>8</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841666524">
        <label>3.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Moore</surname>
            <given-names>C L</given-names>
          </name>
          <name>
            <surname>Bomann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Daniels</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone--the STONE score: retrospective and prospective observational cohort studies. BMJ.2014;</article-title>
          <fpage>348</fpage>
          <lpage>2191</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841453908">
        <label>4.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Pearle</surname>
            <given-names>M S</given-names>
          </name>
          <name>
            <surname>Calhoun</surname>
            <given-names>E A</given-names>
          </name>
          <name>
            <surname>Curhan</surname>
            <given-names>G C</given-names>
          </name>
          <article-title>Urologic diseases in America project: urolithiasis. J Urol</article-title>
          <date>
            <year>2005</year>
          </date>
          <volume>173</volume>
          <issue>3</issue>
          <fpage>848</fpage>
          <lpage>57</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841447932">
        <label>5.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Evan</surname>
            <given-names>A P</given-names>
          </name>
          <name>
            <surname>Coe</surname>
            <given-names>F L</given-names>
          </name>
          <name>
            <surname>Lingeman</surname>
            <given-names>J E</given-names>
          </name>
          <article-title>Mechanism of formation of human calcium oxalate renal stones on Randall&amp;apos;s plaque. Anat Rec (Hoboken)</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>290</volume>
          <issue>10</issue>
          <fpage>1315</fpage>
          <lpage>23</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841439964">
        <label>6.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Chandhoke</surname>
            <given-names>P S</given-names>
          </name>
          <article-title>Evaluation of the recurrent stone former. Urol Clin North Am</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>34</volume>
          <issue>3</issue>
          <fpage>315</fpage>
          <lpage>22</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841437876">
        <label>7.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Fung</surname>
            <given-names>G S</given-names>
          </name>
          <name>
            <surname>Kawamoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matlaga</surname>
            <given-names>B R</given-names>
          </name>
          <article-title>Differentiation of kidney stones using dual-energy CT with and without a tin filter</article-title>
          <date>
            <year>2012</year>
          </date>
          <source>AJR Am</source>
          <fpage>1380</fpage>
          <lpage>6</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841424724">
        <label>8.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Primak</surname>
            <given-names>A N</given-names>
          </name>
          <name>
            <surname>Fletcher</surname>
            <given-names>J G</given-names>
          </name>
          <name>
            <surname>Vrtiska</surname>
            <given-names>T J</given-names>
          </name>
          <article-title>Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol</article-title>
          <date>
            <year>2007</year>
          </date>
          <volume>14</volume>
          <issue>12</issue>
          <fpage>1441</fpage>
          <lpage>7</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841422780">
        <label>9.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Qu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ramirez-Giraldo</surname>
            <given-names>J C</given-names>
          </name>
          <name>
            <surname>Leng</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Dual-energy dual-source CT with additional spectral filtration can improve the differentiation of nonuric acid renal stones: an ex vivo phantom study</article-title>
          <date>
            <year>2011</year>
          </date>
          <source>AJR Am</source>
          <fpage>1279</fpage>
          <lpage>87</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841426164">
        <label>10.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Patschan</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Ketelsen</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Dual-energy CT for the characterization of urinary calculi: In vitro and in vivo evaluation of a low-dose scanning protocol. Eur Radiol</article-title>
          <date>
            <year>2009</year>
          </date>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>1553</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841403876">
        <label>11.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Stolzmann</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kozomara</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chuck</surname>
            <given-names>N</given-names>
          </name>
          <article-title>In vivo identification of uric acid stones with dual-energy CT: diagnostic performance evaluation in patients. Abdom Imaging</article-title>
          <date>
            <year>2009</year>
          </date>
        </mixed-citation>
      </ref>
      <ref id="ridm1841401788">
        <label>12.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Vrtiska</surname>
            <given-names>T J</given-names>
          </name>
          <name>
            <surname>Krambeck</surname>
            <given-names>A E</given-names>
          </name>
          <name>
            <surname>McCollough</surname>
            <given-names>C H</given-names>
          </name>
          <article-title>Imaging Evaluation and Treatment of Nephrolithiasis: An Update. Minnesota medicine</article-title>
          <date>
            <year>2010</year>
          </date>
          <volume>93</volume>
          <issue>8</issue>
          <fpage>48</fpage>
          <lpage>51</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841395596">
        <label>13.</label>
        <mixed-citation xlink:type="simple" publication-type="journal">
          <name>
            <surname>Bres–Niewada</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Dybowski</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Radziszewski</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Predicting stone composition before treatment – can it really drive clinical decisions?</article-title>
          <date>
            <year>2014</year>
          </date>
          <source>Central European Journal of Urology</source>
          <volume>67</volume>
          <issue>4</issue>
          <fpage>392</fpage>
          <lpage>396</lpage>
        </mixed-citation>
      </ref>
      <ref id="ridm1841393364">
        <label>14.</label>
        <mixed-citation xlink:type="simple" publication-type="book">
          <name>
            <surname>Eliahou</surname>
            <given-names>Ruth</given-names>
          </name>
          <name>
            <surname>Hidas</surname>
            <given-names>Guy</given-names>
          </name>
          <name>
            <surname>Duvdevani</surname>
            <given-names>Mordechai</given-names>
          </name>
          <name>
            <surname>Sosna</surname>
            <given-names>Jacob</given-names>
          </name>
          <article-title>Determination of Renal Stone Composition with Dual-Energy Computed Tomography: An Emerging Application</article-title>
          <date>
            <year>2010</year>
          </date>
          <chapter-title>Seminars in Ultrasound, CT and MRI, Volume 31, Issue 4</chapter-title>
          <fpage>315</fpage>
          <lpage>320</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
